Efficacy and tolerability of mirabegron compared with solifenacin for children with idiopathic overactive bladder: A preliminary study.

Seong Cheol Kim Myungchan Park Chongsok Chae Ji Hyung Yoon Teakmin Kwon Sejun Park Kyung Hyun Moon Sang Hyeon Cheon Sungchan Park

Published in: Investigative and clinical urology (2021)

Mirabegron showed comparable efficacy to solifenacin in pediatric patients with idiopathic OAB. Additionally, only few adverse effects were reported, suggesting that mirabegron can be a safe alternative for the treatment of idiopathic pediatric OAB.

Keyphrases

young adults
open label
randomized controlled trial
combination therapy
placebo controlled
smoking cessation